Free Trial
NASDAQ:BHST

BioHarvest Sciences (BHST) Stock Price, News & Analysis

BioHarvest Sciences logo
$7.05 -0.13 (-1.81%)
As of 07/16/2025 03:59 PM Eastern

About BioHarvest Sciences Stock (NASDAQ:BHST)

Key Stats

Today's Range
$7.05
$7.16
50-Day Range
$6.10
$7.66
52-Week Range
$4.66
$7.86
Volume
4,210 shs
Average Volume
6,553 shs
Market Capitalization
$115.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.67
Consensus Rating
Buy

Company Overview

Receive BHST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioHarvest Sciences and its competitors with MarketBeat's FREE daily newsletter.

BHST Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
BioHarvest enters fragrance industry with AI edge - ICYMI
See More Headlines

BHST Stock Analysis - Frequently Asked Questions

BioHarvest Sciences' stock was trading at $6.18 at the beginning of the year. Since then, BHST stock has increased by 14.1% and is now trading at $7.05.

BioHarvest Sciences Inc. (NASDAQ:BHST) posted its earnings results on Thursday, May, 15th. The company reported ($0.13) EPS for the quarter, beating analysts' consensus estimates of ($0.15) by $0.02. The company had revenue of $7.64 million for the quarter, compared to the consensus estimate of $8.93 million. BioHarvest Sciences had a negative net margin of 31.30% and a negative trailing twelve-month return on equity of 307.04%.
Read the conference call transcript
.

BioHarvest Sciences' top institutional investors include Magnus Financial Group LLC (0.43%) and True North Advisors LLC (0.13%).

Shares of BHST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2025
Today
7/16/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BHST
Previous Symbol
NASDAQ:BHST
CIK
1723464
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$15.00
Low Price Target
$12.00
Potential Upside/Downside
+93.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.50)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.91 million
Net Margins
-31.30%
Pretax Margin
-31.13%
Return on Equity
-307.04%
Return on Assets
-33.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.51
Quick Ratio
0.30

Sales & Book Value

Annual Sales
$25.19 million
Price / Sales
4.60
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.08 per share
Price / Book
88.13

Miscellaneous

Outstanding Shares
16,420,000
Free Float
N/A
Market Cap
$115.76 million
Optionable
N/A
Beta
0.65
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:BHST) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners